Expansion opportunities Klosterfrau has a presence across Europe, North America, Africa and Asia with a Cologne HQ and in‑house R&D labs. This suggests potential for cross‑border distribution partnerships, contract manufacturing collaborations, or channel extensions to introduce new or legacy brands into emerging markets.

Acquisition / exit Recent sale of Hermes Süssstoff brands to Krüger Group indicates active portfolio optimization and readiness to divest non-core assets. Sales opportunities may exist in pursuing value‑in‑kind/brand licensing or co‑development deals for other underperforming SKUs or for regional brand rotation in partner portfolios.

PP syringe collaboration Joint development with Sanner Group on polypropylene syringe systems shows openness to advanced packaging and delivery solutions. Target opportunities include sterile packaging, auto‑disable syringe components, and complementary medical device integrations for analgesics, cough, or OTC therapies.

Natural‑based positioning A strong emphasis on the healing power of nature and a diversified portfolio of over 30 brands supports a sales angle around natural/plant‑based OTC products. Opportunities exist to expand into retailers and pharmacies prioritizing natural health lines and to develop private label or co‑branded options aligned with wellness trends.

SMB to mid‑tier fit Revenue range and mid‑sized footprint (200–500 employees) suggest capacity for scalable partnerships, including white‑label manufacturing, regional distribution agreements, and strategic collaborations with mid‑market distributors to accelerate penetration in Central and Eastern Europe and beyond.